No, we are not ok. An article about why drug ads are permitted: https://t.co/8bZwlAxtNi If you’re like me, & just scan articles to get to the study they mention, here’s the direct link: https://t.co/AWIVCOOBAH https://t.co/YbfcMr7uG3
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Great to see this guidance document, as we showed earlier this year in @JournalGIM, among nearly 100 DTC television ads, non…
RT @jsross119: Great to see this guidance document, as we showed earlier this year in @JournalGIM, among nearly 100 DTC television ads, non…
RT @jsross119: Great to see this guidance document, as we showed earlier this year in @JournalGIM, among nearly 100 DTC television ads, non…
RT @jsross119: Great to see this guidance document, as we showed earlier this year in @JournalGIM, among nearly 100 DTC television ads, non…
Great to see this guidance document, as we showed earlier this year in @JournalGIM, among nearly 100 DTC television ads, none described drug risks quantitatively and only 25% did so for drug efficacy https://t.co/xJPDLrCUAX
RT @jamesian: T2- Outlandish claims of pharma in ads on TV are poorly regulated. https://t.co/2R9Kwy6ORl Research on that #hcdr https://t.c…
T2- Outlandish claims of pharma in ads on TV are poorly regulated. https://t.co/2R9Kwy6ORl Research on that #hcdr https://t.co/1xlZLrenb4
RT @jsross119: As we've shown in a couple of studies of journal ads to physicians (https://t.co/klxQ3pc1Y3) and direct-to-consumer televisi…
RT @jsross119: As we've shown in a couple of studies of journal ads to physicians (https://t.co/klxQ3pc1Y3) and direct-to-consumer televisi…
As we've shown in a couple of studies of journal ads to physicians (https://t.co/klxQ3pc1Y3) and direct-to-consumer television ads (https://t.co/4PKvI3UZWa) @JournalGIM @PLOSONE
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
DTC ads #OffLabel Promotion and Adherence #FDA Guidelines https://t.co/qfJ9mDrLy5
RT @iGas2: May we never go down the Direct To Consumer path for #PBS items! #BigPharma behaving badly. Via @pash22 https://t.co/qzi820Km2L
May we never go down the Direct To Consumer path for #PBS items! #BigPharma behaving badly. Via @pash22 https://t.co/qzi820Km2L
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
This month I recommend an article from @jsross119 about direct-to-consumer advertising. #DTCA #pharma https://t.co/oeMJ0caJFn
Thank you for doing this study @jsross119! There's a reason the vast majority of the world does not allow direct-to-consumer prescription advertising. https://t.co/DEuUUDtVJz
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to #FDA Guidelines. https://t.co/GmtsCRgnbu
RT @JuanGrvas: USA. Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Frequent Off-Label Promotion and Low Adherence to FD…
RT @JuanGrvas: EEUU. Anuncios de medicamentos a la población. Baja adherencia a las normas de la FDA y frecuente sugerencia de uso fuera d…
RT @JuanGrvas: USA. Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Frequent Off-Label Promotion and Low Adherence to FD…
EEUU. Anuncios de medicamentos a la población. Baja adherencia a las normas de la FDA y frecuente sugerencia de uso fuera de indicación. https://t.co/DpK0mhIqdA
USA. Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Frequent Off-Label Promotion and Low Adherence to FDA Guidelines. https://t.co/DpK0mhIqdA
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
US Direct to consumer broadcast adverts for pharmaceuticals: Off label promotion & adherence to @US_FDA guidelines https://t.co/ouFZ3oWwg0 via @jsross119 Very disappointing results!
RT @LizSzabo: So much hype. https://t.co/ZkqTWWqNfs
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
I think we just stop advertising drugs... https://t.co/nb4kj9bFwX
So much hype. https://t.co/ZkqTWWqNfs
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
Yes, info re wt loss is usually in Clinical Studies Sect 14 of the PI. The authors argue that this claim is purported to be an indication, when it is not. Full publication here: https://t.co/80wEb9lblB (which I originally posted March 3, because that's how
RT @PharmerRob: DTC Broadcast Ads for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines https://t.co/MyR9v4V0OE
DTC Broadcast Ads for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines https://t.co/MyR9v4V0OE
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @HandNF: The US is one of the only countries allowed to advertise pharmaceuticals. Imagine the cost of drugs if they didn't have to cove…
I've always hated drug ads. Turns out they (we?) don't even bother to follow the rules: https://t.co/xcZF69HOrq
Few DTC ads where fully compliant with FDA guidelines especially regarding off label usage (Research) #DTC #pharma #pharmaadvertising #offlabel #health https://t.co/ET74M4kJFo
Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines | SpringerLink https://t.co/caB1IGgQct
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @foxerinr: Great support for getting rid of DTC ads! https://t.co/0rTWIfeEcO
Mad Med. Direct to consumer advertising fails to present benefits & harms of medicines according to FDA guidelines https://t.co/EGXuaxozL2
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
How about let's stop advertising? https://t.co/B6yAkAhKnN
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @chngin_the_wrld: Today's #shoutout to #WomeninSTEM goes to Kristina Klara for her @JournalGIM paper that shows that most direct-to-cons…
Today's #shoutout to #WomeninSTEM goes to Kristina Klara for her @JournalGIM paper that shows that most direct-to-consumer ads for #prescription #drugs are not fully #FDA compliant and inappropriate off-label uses for #diabetes medications were common http
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @JoshuaDWallach: Fascinating piece by @Yale_CRIT colleagues: review of 18 months of pharmaceutical tv ads: 0 quantified safety risks, 13…
RT @JoshuaDWallach: Fascinating piece by @Yale_CRIT colleagues: review of 18 months of pharmaceutical tv ads: 0 quantified safety risks, 13…
RT @JoshuaDWallach: Fascinating piece by @Yale_CRIT colleagues: review of 18 months of pharmaceutical tv ads: 0 quantified safety risks, 13…
Yes, the value of advertising pharmaceuticals in 30 to 60 second clips, with attractive actors portraying benefits? More risks than benefits? All about increasing sales -- and profits? https://t.co/vdMNa51P1t
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
Fascinating piece by @Yale_CRIT colleagues: review of 18 months of pharmaceutical tv ads: 0 quantified safety risks, 13% suggested off-label uses, median 16 risks/ad (2 s per claim). Many other concerning characteristics. Additional oversight necessary? ht
Follow Canadian lead and stop drug advertising @US_FDA https://t.co/4YlLQb5vM0
RT @HandNF: The US is one of the only countries allowed to advertise pharmaceuticals. Imagine the cost of drugs if they didn't have to cove…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
If we ever update the direct to consumer ads #mythbuster / are they educational? Nope @CFHI_FCASS @CFHI_BCallery @CFHI_MRossiter https://t.co/4HLEhuCh6G
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @damienmiller: For someone coming from a country with medical advertising restrictions, drug ads in the USA are completely bonkers https…
The US is one of the only countries allowed to advertise pharmaceuticals. Imagine the cost of drugs if they didn't have to cover marketing costs. https://t.co/hIoogDRkIJ
As with insurance, I'm going to suggest the U.S., as usual, catch up with the rest of the developed world. https://t.co/zgvViZzw1o
RT @foxerinr: Great support for getting rid of DTC ads! https://t.co/0rTWIfeEcO
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…
RT @jsross119: Our review of 18 months of pharmaceutical tv ads - you've seen them all! - none quantified safety risks, only 1/4 did so for…